609:
544:
205:
led the round and was joined by new and existing investors. In April 2015, the company raised $ 225M in exchange for 1.5% of future global net sales of ITCA 650. In May 2016, Intarcia secured an additional $ 75M in financing to scale-up manufacturing and inventory in anticipation of ITCA 650s global
158:
In 2005, the executive leadership of
Intarcia was largely vested in two people, Karling Leung and James Ahlers, President/CEO/Director and Vice President/CFO/Finance & Operations Officer, respectively. By 2012, Kurt Graves had replaced Karling Leung as President and CEO. Kurt Graves has been
151:. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. In 2013, Intarcia relocated its headquarters to Boston, keeping its manufacturing facility in Hayward, CA. In addition to Boston and Hayward, Intarcia also has a location in
170:
delivered via its Medici Drug
Delivery System, "a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides". The drug was rejected for FDA approval in 2017 and 2020.
675:
206:
launch. In
September 2016, Intarcia raised an additional $ 215M in equity financing to prepare for the commercial launch of ITCA 650 in late 2017 and additional pipeline programs.
670:
491:
227:
665:
593:
646:
313:
264:
287:
35:
690:
335:
680:
685:
586:
639:
258:
237:
340:
305:
179:
159:
with
Intarcia since August 2010, first serving as Executive Chairman before becoming President and CEO in April 2012.
406:
509:
579:
183:
421:"AtTaIntarcia raises $ 210M as it pushes once-a-year diabetes treatment into Phase III, moves HQ to Boston area"
632:
473:
336:"Intarcia raises $ 210M as it pushes once-a-year diabetes treatment into Phase III, moves HQ to Boston area"
55:
232:
191:
178:
In
November 2012, Intarcia received $ 210M in preferred stock and debt financing from, The Baupost Group,
152:
45:
65:
492:"Intarcia raises $ 75M, touts final data as it preps to launch once-yearly diabetes drug implant"
384:
187:
140:
559:
34:
163:
616:
563:
555:
446:
379:
17:
659:
195:
380:"Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus"
420:
288:"Investors pump $ 200M into Intarcia's PhIII for once-yearly diabetes therapy"
202:
144:
85:
167:
361:
162:
As of 2016, Intarcia is engaged in development of a "potential once-a-year
407:"Intarcia's diabetes drug implant ITCA 650 receives second FDA rejection"
155:, where it discovers and develops peptides for its drug delivery system.
148:
608:
551:
543:
201:
In April 2014, Intarcia secured an additional $ 200M in financing.
166:
treatment". Referred to as ITCA 650, the therapeutic consists of
529:
620:
615:
This United States corporation or company article is a
567:
125:
510:"Diabetes 'Unicorn' Raises Final VC Round Before IPO"
282:
280:
222:
220:
218:
120:
112:
96:
80:
61:
51:
41:
228:"Company Overview of Intarcia Therapeutics, Inc."
676:Pharmaceutical companies of the United States
640:
587:
8:
671:Health care companies based in Massachusetts
105:Kurt C. Graves (Chairman, President and CEO)
27:
647:
633:
594:
580:
33:
26:
474:"Startup Intarcia Raises $ 225 Million"
214:
153:Research Triangle Park, North Carolina
7:
605:
603:
540:
538:
147:and incorporated under the laws of
25:
666:1995 establishments in California
607:
542:
186:, New Leaf Venture Partners and
472:Winslow, Ron (April 28, 2015).
334:Ron Leuty (November 15, 2012),
198:and Granite Venture Partners.
1:
306:"INTARCIA THERAPEUTICS, INC."
619:. You can help Knowledge by
566:. You can help Knowledge by
562:corporation or company is a
341:San Francisco Business Times
691:United States company stubs
310:AMENDMENT NO. 1 TO FORM S-1
190:. Other Investors include
180:Farallon Capital Management
116:Medici Drug Delivery System
28:Intarcia Therapeutics, Inc.
707:
602:
537:
681:Companies based in Boston
184:New Enterprise Associates
32:
480:– via www.wsj.com.
56:pharmaceutical industry
451:Greenspring Associates
233:Bloomberg Businessweek
192:Greenspring Associates
18:BioMedicines (company)
686:Medical company stubs
550:This article about a
496:www.fiercebiotech.com
292:www.fiercebiotech.com
137:Intarcia Therapeutics
68:, United States (1995
447:"Direct Investments"
478:Wall Street Journal
427:. November 15, 2012
240:on January 18, 2013
66:Hayward, California
29:
453:. November 7, 2013
385:ClinicalTrials.gov
188:Venrock Associates
628:
627:
575:
574:
143:company based in
141:biopharmaceutical
134:
133:
16:(Redirected from
698:
649:
642:
635:
611:
604:
596:
589:
582:
560:biotechnological
546:
539:
530:Official website
518:
517:
506:
500:
499:
488:
482:
481:
469:
463:
462:
460:
458:
443:
437:
436:
434:
432:
417:
411:
410:
409:. 27 March 2020.
403:
397:
396:
395:
393:
376:
370:
369:
358:
352:
351:
350:
348:
331:
325:
324:
323:
321:
316:, March 18, 2005
302:
296:
295:
284:
275:
274:
273:
271:
255:
249:
248:
247:
245:
236:, archived from
224:
130:
127:
75:
73:
37:
30:
21:
706:
705:
701:
700:
699:
697:
696:
695:
656:
655:
654:
653:
601:
600:
535:
526:
521:
508:
507:
503:
490:
489:
485:
471:
470:
466:
456:
454:
445:
444:
440:
430:
428:
419:
418:
414:
405:
404:
400:
391:
389:
378:
377:
373:
360:
359:
355:
346:
344:
333:
332:
328:
319:
317:
304:
303:
299:
286:
285:
278:
269:
267:
257:
256:
252:
243:
241:
226:
225:
216:
212:
176:
164:type 2 diabetes
139:is an American
124:
108:
99:
92:
88:
71:
69:
23:
22:
15:
12:
11:
5:
704:
702:
694:
693:
688:
683:
678:
673:
668:
658:
657:
652:
651:
644:
637:
629:
626:
625:
612:
599:
598:
591:
584:
576:
573:
572:
556:pharmaceutical
547:
533:
532:
525:
524:External links
522:
520:
519:
501:
483:
464:
438:
412:
398:
371:
353:
326:
297:
276:
250:
213:
211:
208:
175:
172:
132:
131:
122:
118:
117:
114:
110:
109:
107:
106:
102:
100:
97:
94:
93:
90:
84:
82:
78:
77:
63:
59:
58:
53:
49:
48:
43:
39:
38:
24:
14:
13:
10:
9:
6:
4:
3:
2:
703:
692:
689:
687:
684:
682:
679:
677:
674:
672:
669:
667:
664:
663:
661:
650:
645:
643:
638:
636:
631:
630:
624:
622:
618:
613:
610:
606:
597:
592:
590:
585:
583:
578:
577:
571:
569:
565:
561:
557:
553:
548:
545:
541:
536:
531:
528:
527:
523:
515:
511:
505:
502:
498:. 9 May 2016.
497:
493:
487:
484:
479:
475:
468:
465:
452:
448:
442:
439:
426:
422:
416:
413:
408:
402:
399:
388:, May 1, 2012
387:
386:
381:
375:
372:
367:
366:Bloomberg.com
363:
357:
354:
343:
342:
337:
330:
327:
315:
311:
307:
301:
298:
294:. April 2014.
293:
289:
283:
281:
277:
266:
262:
261:
254:
251:
239:
235:
234:
229:
223:
221:
219:
215:
209:
207:
204:
199:
197:
196:Alta Partners
193:
189:
185:
181:
173:
171:
169:
165:
160:
156:
154:
150:
146:
142:
138:
129:
123:
119:
115:
111:
104:
103:
101:
95:
91:United States
87:
83:
79:
67:
64:
60:
57:
54:
50:
47:
44:
40:
36:
31:
19:
621:expanding it
614:
568:expanding it
549:
534:
513:
504:
495:
486:
477:
467:
455:. Retrieved
450:
441:
429:. Retrieved
424:
415:
401:
392:November 15,
390:, retrieved
383:
374:
365:
356:
347:November 15,
345:, retrieved
339:
329:
320:November 15,
318:, retrieved
309:
300:
291:
270:November 15,
268:, retrieved
259:
253:
244:November 15,
242:, retrieved
238:the original
231:
200:
177:
161:
157:
136:
135:
81:Headquarters
42:Company type
457:November 7,
431:November 7,
425:BizJournals
260:Exhibit 4.1
660:Categories
203:RA Capital
145:Boston, MA
98:Key people
86:Boston, MA
174:Investors
168:exenatide
362:"Stocks"
149:Delaware
126:intarcia
113:Products
52:Industry
552:medical
514:Fortune
121:Website
70: (
62:Founded
46:Private
210:Notes
617:stub
564:stub
459:2013
433:2013
394:2012
349:2012
322:2012
272:2012
246:2012
128:.com
72:1995
558:or
314:SEC
265:SEC
662::
554:,
512:.
494:.
476:.
449:.
423:.
382:,
364:.
338:,
312:,
308:,
290:.
279:^
263:,
230:,
217:^
194:,
182:,
89:,
648:e
641:t
634:v
623:.
595:e
588:t
581:v
570:.
516:.
461:.
435:.
368:.
76:)
74:)
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
